首页> 外文期刊>Nephrology Dialysis Transplantation >Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient
【24h】

Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient

机译:肾交感神经消融治疗血液透析患者难于控制或难治性高血压

获取原文
获取原文并翻译 | 示例
           

摘要

Haemodialysis patients show sympathetic hyperactivity. Hyperactivation of the sympathetic nervous system aggravates hypertension and it is related to left ventricular hypertrophy, heart failure, arrhythmias and atherogenesis. We report the first use of renal sympathetic nerve ablation for correction of uncontrolled hypertension in an end-stage renal disease patient on maintenance dialysis. We observed a progressive and sustained reduction of systemic blood pressure. Our case demonstrates the safety, the feasibility and the efficacy of this procedure. These findings suggest, however, that further clinical trials are needed into renal nerve radiofrequency ablation therapy for the treatment of hypertension and for the improvement of cardiovascular prognosis in this high-risk patient group.
机译:血液透析患者表现出交感神经亢进。交感神经系统过度活化会加重高血压,它与左心室肥大,心力衰竭,心律不齐和动脉粥样硬化有关。我们报道了在维持性透析的终末期肾脏疾病患者中,首次使用肾脏交感神经消融术纠正无法控制的高血压。我们观察到系统性血压持续下降。我们的案例证明了该程序的安全性,可行性和有效性。然而,这些发现表明,在该高危患者组中,肾神经射频消融治疗需要进一步的临床试验,以治疗高血压和改善心血管预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号